We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-6 of 6

The European Commission’s consultation on increased cooperation between NCAs in multijurisdictional mergers

  • Hogan Lovells
  • -
  • European Union
  • -
  • July 19 2011

The European Commission is currently considering responses received to its consultation on draft Best Practices for Cooperation Among EU National Competition Authorities in merger cases (“draft Best Practices”

Varian acquisition of Agilent gains conditional approval from European Commission

  • Hogan Lovells
  • -
  • European Union
  • -
  • March 11 2010

On January 21, 2010 the European Commission (Commission) gave its conditional approval to the acquisition of Varian Inc by Agilent Technologies Inc

European Commission pharmaceutical sector inquiry Final Report drug problems remain but Commission softens its stance

  • Hogan Lovells
  • -
  • European Union
  • -
  • July 30 2009

On July 8, 2009 the European Commission (EC) published its long-awaited final report on its inquiry into the pharmaceutical sector (Final Report

European Commission pharmaceutical sector inquiry final report drug problems remain but Commission softens its stance

  • Hogan Lovells
  • -
  • European Union
  • -
  • July 15 2009

On July 8, 2009 the European Commission (the Commission) published its long-awaited final report on its inquiry into the pharmaceutical sector (the Final Report

German Cartel Office imposes fines for gun jumping

  • Hogan Lovells
  • -
  • Germany
  • -
  • May 26 2009

Within the last six months the German Federal Cartel Office imposed heavy fines on US nutrition and pet food producer Mars and a German press publishing house for allegedly breaching German merger control rules by closing transactions before merger control clearance ("gun jumping"

European Commission signals new approach to relevant product market definition in pharmaceutical merger cases

  • Hogan Lovells
  • -
  • European Union
  • -
  • March 29 2009

On February 4, 2009, the European Commission approved Sanofi-Aventis’s acquisition of Czech generics pharmaceutical manufacturer Zentiva

Current Search

Suggested Facets

Author

Jurisdiction

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy